Understand migraine pathophysiology and allodynia

Pathophysiology: What Happens in Your Brain During a Migraine

First, what is pathophysiology? Pathophysiology refers to the changes that occur in the body’s systems, resulting in abnormal function, as a result of an illness, a disease, or an abnormal condition such as migraine. Scientists are constantly learning new information about what happens in your brain at the start of a migraine and during a headache.

Most of us have probably heard about changes in blood vessels associated with migraine headaches. It might seem that blood vessels constrict during a migraine—that would seem logical, wouldn’t it? And so they do, some of them—but the entire situation is not as simple as originally thought.

Initially, it was thought that the blood vessels on the surface of your brain dilate, and with each heartbeat, the blood surging through throws the dilated blood vessel wall up against your skull, resulting in that throbbing pounding pain you are so familiar with. And migraines were termed “vascular headaches”. Recently, that phenomenon has been thrown into doubt, although various experts disagree. Certainly, though, it is not as simple as just blood vessel changes.

Migraine mostly happens within your brain. Several things happen at the beginning of a migraine attack, and we are not yet sure exactly what happens first, or whether one leads to another.

CHANGES IN YOUR BRAIN—CORTICAL SPREADING DEPRESSION

We know that there are waves of electrical changes that go across the brain, starting at the back and moving slowly towards the front. First there is a wave of excitation, followed by what is called spreading cortical depression. This has been known since the 1940s, when it was discovered in rabbits by a Brazilian neurologist named Leão, although it wasn’t immediately associated with migraine at that time. Interestingly, though, there was another neurologist at about that time (named Lashley) who tracked the spread of his own visual auras, and found that they moved at about 2-3 mm/minute. This is about the same speed as cortical spreading depression.

We have since made an association between cortical spreading depression and migraine aura. And, in fact, we have been able to demonstrate very slow changes moving across the brain during migraine aura on both blood oxygen level dependent (BOLD) MRI studies and magnetoencephalography. These changes move at a rate consistent with the speed of cortical spreading depression. Although most of these studies have been done in migraine with aura, there is one PET study done in a single patient who has migraine without aura showing slowing of blood flow in a similar pattern, suggesting that cortical spreading depression may occur in migraine without aura as well. Obviously, it is much harder to study in migraine without aura, as it is more difficult to determine when the beginning of the attack is in order to test it.

Recent studies of blood vessels in the brain during cortical spreading depression show that there is constriction of the blood vessels as the waves of spreading depression pass over the brain. There is also a drop in oxygenation of that segment of the brain as a consequence. Yes, you’re right—that’s not a good thing. Fortunately, it does not last long until the wave passes along.

Brainstem Activation

There is also evidence of brainstem activation at the beginning of a migraine. Areas of the brainstem show up as brightly active on PET scans in the beginning of a migraine attack. These studies have indicated that brainstem activation occurs in both migraine with and without aura.

If you like, take a look at diagrams of the brainstem and other brain areas.

So is this what causes the pain? Well, yes and no. We know that these areas of the brainstem—the raphé nucleus, and the locus cœruleus—are important in the maintenance of mood and the processing of pain. Other brainstem areas, the substantia nigra and the red nucleus, were previously thought to be more important for normal movement, and we have found recently that they have a role in headache pain as well.

But that’s not the whole migraine pain story. We still haven’t gotten to the inside of your head, really. Everything we have talked about so far has happened at the base of the brain or on its surface. And we haven’t really covered that in detail yet.

EXCITABLE NEURONS

Based on research, the best understanding we now have is that migraine arises from abnormally excitable neurons in the brain and trigeminal nerve. What causes the neurons to be abnormally excitable? Various things can do this, including low magnesium, abnormal calcium channels on the surface of the neuron, mitochondrial abnormalities, or other inherited brain chemical abnormalities. The newest things in the migraine story are the glia—the support cells in the brain—which also appear to have a role in transmitting pain, perhaps moreso in chronic headache, although their story is still being determined.

The trigeminal nerves start in the brainstem in the trigeminal nucleus caudalis, and travel to your face, teeth, eyes, sinuses, and forehead. They also go to the blood vessels on the surface of the brain. So, now we have excitable neurons, and (maybe) dilating blood vessels. These make up what we call the trigeminovascular system, or trigeminovascular theory of migraine.

Now, why “maybe”? A recent study has shown that this may not actually be the case, and that “vascular” headaches may not even be vascular at all! A study in Brain conducted by Schoonman et al induced experimental migraine in both migraine sufferers and control subjects with intravenous nitroglycerine. The controls developed dilation of the meningeal vessels (the ones on the surface of the brain); the migraineurs did not.

This result casts some doubt on the trigeminovascular theory, particularly if these results are replicated by other similar studies.

While there is still some controversy over the “vascular” part of migraine, the situation was recently summed up by Dr. Andrew Charles, UCLA migraine researcher. Dr. Charles indicated that while it is clear that vascular changes occur in migraine, it does not mean migraine is triggered by vascular processes, and that the dilation of blood vessels is neither necessary nor sufficient for causing migraine pain.

According to existing trigeminovascular theory, once the messages come from the activated cells in the trigeminal nucleus in the brainstem, and travel to the trigeminal nerves that go to the dural blood vessels on the brain’s surface, it causes dilation. However, the trigeminal activation also causes the release of brain chemicals called neuropeptides (substance P, CGRP or calcitonin gene-related peptide, neurokinin A, 5HT or serotonin, and noradrenalin.)

ALLODYNIA

The release of these chemicals causes inflammation, and what is called peripheral sensitization. This is most likely what results in the throbbing pain most people experience. As the attack progresses, something can occur called central sensitization. When this occurs, it causes what is known as cutaneous allodynia. This means that things that are usually just a normal touch are now felt as painful. Many headache patients with allodynia cannot continue to wear earrings, necklaces or neckties, or their glasses. Some find that they cannot lie down on the side of the head pain, or report that “even their hair hurts.” Up to 80% of migraine sufferers are affected by some degree of cutaneous allodynia, and it generally occurs in the late stages of a migraine attack when the pain is severe. This is why it is important to treat early when the pain is mild or moderate.

When central sensitization becomes advanced, it can involve areas beyond the head, and simple touch on the arms or shoulder can be perceived as painful. For example, I am aware of one migraine sufferer who is bothered by the seams in her clothing during such an attack. At this stage of the migraine, migraine-specific medication is less likely to be helpful, and studies have shown that while they will reduce the pain and relieve the throbbing, they cannot abort the attack, and allodynic pain remains as well as other migraine symptoms.

In late-stage migraine, other medications may be necessary in order to end the attack. We do not yet have migraine-specific medications designed for the late stage of the migraine attack, although research into migraine pathophysiology is ongoing. As we learn more, it should lead to better developments in the treatment of migraine.

References:

1. Leão, APP. Spreading depression of activity in the cerebral cortex. J. Neurophysiol. 1944; 7:359-90.

2. Leão, APP, Morison, RS. Propagation of spreading cortical depression. Neurophysiol.1945; 8:33-45.

3. Lashley K. Patterns of cerebral integration indicated by scotomas of migraine. Arch. Neurol. Psychiatry 1941; 46: 331-339.

4. Charles A, Brennan K. Cortical Spreading Depression—New Insights and Persistent Questions. Cephalalgia. 2009;29(10):1115 -1124.

5. Malick A, Burstein R. Peripheral and central sensitization during migraine. Funct. Neurol. 2000;15 Suppl 3:28-35.

6. Olesen J, Larsen B, Lauritzen M. Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Annals of Neurology. 1981; 9,344-352.

7. Burstein R, Cutrer MF, Yarnitsky D. The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain. 2000;123 ( Pt 8):1703-1709.

8. Burstein R, Yarnitsky D, Goor-Aryeh I, Ransil BJ, Bajwa ZH. An association between migraine and cutaneous allodynia. Ann. Neurol. 2000;47(5):614-624.

9. Charles, A. Intercellular calcium waves in glia. Glia. 1998; 24:39-49.

10. Schoonman GG, van der Grond J, Kortmann C, et al. Migraine headache is not associated with cerebral or meningeal vasodilatation—a 3T magnetic resonance angiography study. Brain. 2008;131(8):2192 -2200.

11. Hadjikhani N,   Sanchez del Rio M,   Wu  O, Schwartz  D, Bakker D, Fischl B, Kwong KK, Cutrer, FM, Rosen BR, Tootell RBH, Sorensen AG, Moskowitz MA. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. PNAS. 2011;  ,9:4687-4692.

by Christina Peterson, M.D.

Updated June 29, 2021

Other Resources

Resources and Links

You can find more information on migraine at these links:

U.S. National Library of Medicine, National Institutes of Health

www.nlm.nih.gov/medlineplus/migraine.html

The American Migraine Foundation

americanmigrainefoundation.org

National Headache Foundation

www.headaches.org

Alliance for Headache Disorders Advocacy

www.allianceforheadacheadvocacy.org

World Headache  and Migraine Alliance

facebook.com/WHAMAlliance

Help For Headaches

www.helpforheadaches.org

National Institute of Neurological Disorders and Stroke

www.ninds.nih.gov/disorders/headache/headache.htm

Everyday Health Headache and Migraine Center

www.everydayhealth.com

Resources for relaxation:

Dawn Buse, PhD

dawnbuse.com/relaxation

Blogs We Like:

Migraine Again  https://www.migraineagain.com/

The Daily Headache www.Thedailyheadache.com

Headache and Migraine News http://headacheandmigrainenews.com/

Chronic Babe www.chronicbabe.com

War on Headaches  http://waronheadaches.blogspot.com/

Miles for Migraine   milesformigraine.org/news

Webcasts

Migraines in the Workplace  www.everydayhealth.com

Why do women get more migraines than men?  www.everydayhealth.com

How Do You Draw Circles?

How Do You Draw Circles?

Random correlation:  only 46% of the general population draws circles counterclockwise (or anticlockwise), but 64% of migraine sufferers draw circles counterclockwise.  No one knows why.

Cardiac Patients with Migraine

If you have heart disease, your options for migraine treatment used to be limited.  Triptan medications should be avoided.  This is because triptans can decrease the diameter of blood vessels which, if already narrowed by heart disease, can potentially restrict blood flow further and result in heart attack.  A recent study of over 120,000 people with migraine from 10 health plans revealed that 22% of people with a heart condition prohibiting the use of triptans were nevertheless given a triptan prescription.

Are these migraine-specific drugs unsafe for migraine sufferers without heart disease?  Triptans are not known to cause heart disease, and can be safely taken as long as you do not have heart disease.  Safety of these medications in migraineurs who have several risk factors for heart disease is not certain, but often alternatives are recommended.

NSAID Risk in Cardiac Patients

Often, nonsteroidal anti-inflammatory medications are offered for migraine pain instead of or in addition to triptan medications.  However, you may not know that nonsteroidal anti-inflammatory drugs (NSAIDs) can be even more dangerous.  Non-steroidal anti-inflammatory medications can be a cause of risk, even amongst those without heart disease or its risk factors, but is especially risky in cardiovascular conditions.  Conditions at particular risk are stroke, unstable angina, recent bypass surgery, or myocardial infarction.  NSAIDs tend to elevate blood pressure, and this accounts for some of the cardiovascular risk.  In those who already have atherosclerosis, the COX-2 NSAIDs also affect the balance of chemical factors affecting clot formation, tilting things toward clotting.

Using NSIADs increases the risk of recurring myocardial infarctions.  Even short term use–as little as seven days–can increase the risk of another myocardial infarction of death by about 50%.  (Drugs used most commonly in this study were ibuprofen, naproxen, rofecoxib, and celecoxib.)

For those with known cardiovascular disease or risk factors for ischemic heart disease, aspirin, tramadol, or acetaminophen (paracetamol) have previously been the safest choices for the treatment of pain.  Naproxen, although not risk-free, was the safest choice in those who have not responded to those medications. There are now newer options (discussed below.)  Narcotic analgesics may be used as rescue medication.  These are not, however, the best options for migraine attacks. 

NSAIDs should be avoided in those who have heart disease or heart failure.  But what about migraine patients who do not have heart disease?  Current recommendations are to weigh the benefits of these medications against their risks. If over-the-counter nonsteroidal anti-inflammatory medication is required for more than ten days, you should see a doctor.  Also, be aware that ibuprofen can interfere with the ability of aspirin to provide protection against clotting, and should be taken either 30 minutes before or twelve hours after taking low-dose aspirin.

New Options for Migraine Patients with Cardiac Disease

Newer medications for migraine are available that have proven safe in cardiac patients.  These include lasmiditan (Reyvow), rimegepant (Nurtec), and ubrogepant (Ubrelvy).  All three of these can be used for the acute management of migraine, and have been found to be safe for cardiac patients.

References:

1. American Neurological Association (ANA) 136th Annual Meeting:  Poster T1614.  Presented September 27, 2011.

2. Antman, EM, Bennett, JS, Daugherty, A, Furberg, C, Roberts, H, Taubert, KA.  Use of nonsteroidal antiinflammatory drugs:  an update for clinicians:  a scientific statement from the American Heart Association.  Circulation. 2007; 115:1634-1642.

3. Hammad, TA, Graham, DJ, Staffa, JA, Komegay, CJ, Dal Pan, GJ.  Onset of acute myocardial infarction after use of non-steroidal anti-inflammatory drugs.  pharmacoepidemiol Drug Sof. 2008; 17:315-321.

4. Fosbol, EL, Gistason, GH, Jacobsen, S, Folke, F, Hansen, ML, Schramm, TK, Sorensen, R, Rasmussen, JN, Andersen, SS, Abildstrom, SZ, Traerup, J, Poulsen, HE, Rasmussen, S, Kober, L, Torp-Pesersen, C.  Risk of myocardial infraction and death associated with the use of nonsteroidal anti-inflammatory drugs (NSAIDS) among healthy individuals:  a nationwide cohort study.  Clin Pharmacol Ther. 2009; 85:190-197.

5. Gislason, GH, Rasmussen, JN, Abildstorm, SZ, Schramm, TK, Hansen, ML, Fosbol, EL, Sorensen, R, Folke, F, Burch, P, Gadsboll, N, Rasmussen, S, Poulsen, HE, Kober, L, Madsen, M, Torp-Pedersen, C. Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure.  Arch Intern Med. 2009; 169:141-149.

6. Young, WB, Mannix, L, Adelman, JU, and Schechter, AL. Cardiac Risk Factors and the Use of Triptans:  A Survey Study.  Headache:  The Journal of Head and Face Pain. 2000; 40:587-591. 

7. Berman, G, Croop, R, Kudrow, D, Halverson, P, Lovegren, M, Thiry, AC, Conway, CM, Coric, V, Lipton, RB.  Safety of Rimegepant, an Oral CGRP Receptor Antagonist, Plus CGRP Monoclonal Antibodies for Migraine.  Headache:  The Journal of Head and Face Pain. 2020. 60 (8):1734-1742.

8. Shapiro, RE, Hochstetler, HM, Dennehy, EB, Khanna, R, Gautier Doty, E, Berg, PH, Starling, AJ. Lasmiditan for Acute Treatment of Migraine in Patients with Cardiovascular Risk Factors:  Post-hoc Analysis of Pooled Results from 2 Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trials.  j. Headache Pain.  2019. 29; 20(1):90.

 

 

 

Environmental

Environmental Migraine Triggers

Environmental triggers are the things around you in everyday life that can serve as a migraine trigger.  Some of these are obvious, but you mat not have thought about some of the others.  Remember that triggers are additive in their effect, so any of these can combine together, or can combine with other types of triggers, to make you more susceptible to a migraine attack.

Environmental triggers can include the following:

Bright light or glare

Alternating light and dark, such as:

  • Driving along a tree-lined road
  • Stripes, checkerboards or other patterns (on wallpaper, etc.)
  • Sitting too close to the screen in the cinema

High ambient heat

Weather changes

Altitude

Loud sounds or commotion

Odors, including:

  • Cigarette smoke
  • Perfume
  • Household cleaners
  • Gasoline, especially diesel
  • Chemical fumes

Travel

Travel – changes in time zones, the way you eat, etc.

Some of these triggers can be avoided more easily than others.

A good way to track your suspected triggers is to jot them down on a headache diary.

by Christina Peterson, MD

updated June 10, 2020

Causes of Headache

 

Types and Causes of Headaches

Headache is divided into two basic types:  primary and secondary.

Secondary headaches are those that are due to some underlying cause, like a sinus or brain injection, head or neck injury, or a brain tumor.  Most headaches that occur are not due to any kind of secondary cause, and are what we call primary headaches.  Less than 5% of all headaches are secondary headaches.  Although infrequent, there are over a hundred types of secondary headache, which is why there are expert headache doctors.

Primary headaches are those that do not have any sort of underlying cause.  The most commonly occurring primary headache is tension-type headache.  Migraine, also a primary headache, affects about 6% of men in the population, and 18-20% of women, depending on what country you live in.  Cluster headache, a primary headache in the group of headaches known as the trigeminal autonomic cephalgias, is far less common.  So what causes migraine?  In most cases, they are thought to be genetic.  Triggers set off a migraine attack, but are not the cause of the underlying migraine disorder.  The biochemical and physiologic basis of migraine is called pathophysiology, and is quite complex.  We are still figuring out all the things that occur in the brain when a migraine happens. 

by Christina Peterson, M.D.

updated Feb 8, 2020

Is Visual Snow a Migraine Aura?

What is Visual Snow?

Visual snow looks like falling snow, static on a TV, or tiny dots in all or part of the visual field.  It can be considered to be a form of visual hallucination, and can also present as a migraine phenomenon.  The technical term for this is Positive Persistent Visual Disturbance.  Persisting visual snow in a migraineurs is also called persistent aura without infarction.

Visual snow can also be a manifestation of Hallucinogen Persisting Perception Disorder, following the use of hallucinogen drugs (LSD, ecstasy, psychedelic mushrooms, and others).  In HPPD, other visual distortions are frequent, including starbursts, afterimages, palinopsia (trails on moving objects), and others.

In a prospective study of 120 patients with persistent visual snow, substance abuse was present in 40%.  This study found that in addition to visual snow, many patients also experienced floaters (73%), persistent after-images (63%), photophobia (54%), flashes (44%), moving objects leaving trails (palinopsia – 48%), difficulty seeing at night (58%), “little cells that travel on a wiggly path” (57%), and “swirls with eyes closed” (41%).

A more recent study has found that on PET studies, subjects with visual snow had evidence of a brain dysfunction (a hypermetabolic lingual gyrus) that is different from what is found in migraine.  Of 120 patients with “visual snow”, 70 patients also had migraine and 37 had typical migraine aura.  The migraineurs with visual snow were more likely to experience palinopsia (trailing objects or afterimages) as well.

For the migrainous form of persisting visual snow, acetazolamide has been propsed, as well as valproate, topiramate, and lamotrigine.  Visual snow related to HPPD has been managed with pharmaceutical as well as non-pharmaceutical strategies.

References:

1.Chen WT, Fuh JL, Lu SR, Wang SJ. Persistent migrainous visual phenomena might be responsive to lamotrigine. Headache 2001; 41: 823-825.

2. Haan J, Sluis P, Sluis LH, Ferrari MD. Acetazolamide treatment for migraine aura status. Neurology 2000; 55: 1588-1589.

3. Haas DC. Prolonged migraine aura status. Ann Neurol 1982; 11: 197-199.

4. Jäger HR, Giffin NJ, Goadsby PJ. Diffusion- and perfusion-weighted MR imaging in persistent migrainous visual disturbances. Cephalalgia 2005; 25: 323-332.

5.  Rothrock JF. Successful treatment of persistent migraine aura with divalproex sodium. Neurology 1997; 48: 261-262.

6. Rozen TD. Treatment of a prolonged migrainous aura with intravenous furosemide. Neurology 2000; 55: 732-733.

7. Schankin C, et al “Visual snow: a new disease entity distinct from migraine aura” AAN 2012; Abstract S36.006.

8. Schankin, C. J., Maniyar, F. H., Sprenger, T., Chou, D. E., Eller, M. and Goadsby, P. J. (2014), The Relation Between Migraine, Typical Migraine Aura and “Visual Snow”. Headache: The Journal of Head and Face Pain, 54: 957–966.

Post updated 6/17/19

Serotonin Syndrome Basics

Causes of Serotonin Syndrome

Serotonin syndrome is something that becomes newsworthy amongst headache patients from time to time, and has been raised to as recent level of concern because of an FDA alert issued in 2007 regarding the possibility of this problem occurring from mixing antidepressant medications and triptan migraine medications.  Should you worry?  This has actually become somewhat controversial.

So, What is Serotonin Syndrome?

Serotonin syndrome is a very serious drug reaction that can occur from medications that stimulate the neurotransmitter serotonin.  This usually occurs when you take more than one medication that stimulates the serotonin system, but it has also been reported from high doses of anti-depressants in the category called SSRO antidepressants.  Serotonin syndrome has been most commonly reported in overdose situations, and is rare in headache sufferersunless, of course, you are also being treated for depression.

Serotonin syndrome symptoms are:

  • altered mental status
  • fever, rapid heart rate
  • tremor
  • shivering
  • insomnia
  • sweating
  • agitation
  • low or high blood pressure
  • diarrhea
  • nausea
  • neuromuscular problems.

These serotonin syndrome symptoms come on within 24 hours of taking the offending medication, or a change in dosage. The symptoms that define a serious serotonin syndrome are altered mental status, fever, and involuntary neuromuscular movements called clonus.

Are You in Danger of Serotonin Syndrome?

Most likely not.  The doses of tricyclic antidepressants used for the prevention of migraine are usually low doses.  Oral triptan medications, taken alone, have not been found to be associated with serotonin syndrome.  A recent study evaluated over 1700 patients who received sumatriptan injection in addition to an SSRI antidepressant, and there were no cases of serotonin syndrome.

The reason the entire matter has become controversial is this:  there are many types of serotonin (or 5HT) receptors, and not all medications plug into the same kinds of receptors.  The triptan medications bind to the 5HT1B and 5HT1D receptors, and serotonin syndrome is believed to be caused by the 5HT1A and 5HT2A receptors.

The rate of serotonin syndrome occurring in those treated with the SSRI antidepressants has been calculated at 0.5 to 0.9 cases per 1000 patient-months of treatment.  However, there have been no cases of serotonin syndrome reported from triptans alone.  The FDA issued the alert so that physicians would be extra aware of the possibility that these combinations could cause a problem, and to be on the watch for the symptoms.

If you are taking an antidepressant and a triptan, it is unlikely that you are at significant risk unless your dose is high or has been changed.  Remember that it is when you have had a dosage increase that you are at the most risk, and it is usually the addition of a third medication that is the problem, such as an anti-nausea medication. an antibiotic, a second anti-depressant, or an opioid analgesic like fentanyl or Demerol (pethidine).

If you are concerned that you have symptoms that might represent serotonin syndrome, call your doctor or go directly to the emergency room.  Be sure to drink lots of water, as this can help.  If nothing has changed in your medication regimen, and your symptoms are mild or vague, it is probably not serotonin syndrome.

Here is the American Headache Society’s statement on serotonin syndrome.

But What If I Am Being Treated for Depression?

Mood disorders are common in migraine sufferers, and many people do take an SSRI or SNRI antidepressant, either for depression or for pain management.  It is important to stay on your prescribed medicationespecially for antidepressants.  Stopping them abruptly can cause a withdrawal syndrome.  if you have concerns, contact the prescribing physician.  Keep a list of all your medications so that all your doctors and other providers know everything you are taking.  When you are at the most risk for a problem with serotonin syndrome is when you have had a dosage increase, or when another medication that affects the serotonin system has been added.

Serotonin Syndrome Symptoms

To review, early symptoms of serotonin syndrome (and “minor diagnostic criteria”) are agitation, nervousness, insomnia, rapid heart rate, rapid breathing, difficulty breathing, nausea, diarrhea, impaired coordination, dilated pupils, and high or low blood pressure.  Remembersome of these are also going to occur during a headache:  for example, pain can increase blood pressure a little.  Some of these are also symptoms of anxiety, which occurs more commonly in headache sufferers than in the general population.

Later and more serious symptoms of serotonin syndrome are fever, sweating, confusion, a change in mood (like elation, semi-coma, or even deterioration to coma), tremors, chills, muscular rigidity, seriously difficulty breathing, brisk reflexes, and myoclonus (a form of muscle hyper-reactivity.)

You should not panic if you just have some nausea or diarrhea.  Although these can be some of the earlier symptoms of a serotonin syndrome, these are also migraine symptoms for a lot of people.  The things that make a serotonin syndrome dangerous are high fever, high blood pressure, coma (obviously), and muscle rigidity that can lead to respiratory difficulty or collapse.  The thing that a neurologist will look for in the diagnosis of a serotonin syndrome in addition to these is a muscular abnormality called clonus  If you feel that you are developing warning signs, take action and call your doctor.

Are There Other Things That Can Mimic Serotonin Syndrome?

Yes, there are.  Anxiety disorders can cause some of the symptoms, as mentioned, as can migraine itself.  But worthy of discussion in this day and age of energy drinks is caffeine toxicity.

Caffeine-Induced Mental Disorder

The following are the criteria used by mental health professionals to diagnose a caffeine-induced mental disorder from the DSM-IV Diagnostic Manual:

Caffeine-Induced Organic Mental Disorder 305.90; Caffeine Intoxication

Diagnostic Criteria:

1. Recent consumption of caffeine, usually in excess of 250 mg.

2. At least five of the following signs:

  •  restlessness
  •  nervousness
  •  excitement
  •  insomnia
  •  flushed face
  •  diuresis
  •  gastrointestinal disturbance
  •  muscle twitching
  •  rambling flow of thought and speech
  •  tachycardia or cardiac arrhythmia
  •  periods of inexhaustibility
  •  psychomotor agitation

3. Not due to any physical or other mental disorder, such as an Anxiety Disorder. One No-Doz® tablet contains 200 mg of caffeine. Each Excedrin® tablet you take contains 65 mg of caffeine.

If you drink any coffee at all, and take two Excedrin® a day, you have gotten more than 250 mg of caffeine a day.  Ohand a Starbuck’s Vente™ contains about 500 mg of caffeine.  So while, of course it’s important to avoid serotonin syndrome, it’s also important to figure out what’s going on.

Most important:  stay safe, and don’t panic.

References:

1.  Putnam GP, O’Quinn S, Bolden-Watson CP, Davis RL, Gutterman DL, Fox AW. Migraine polypharmacy and the tolerability of sumatriptan: a large-scale, prospective study. Cephalalgia.  1999;19:668- 675.

2. Stewart Tepper, Christopher Allen, David Sanders, Alison Greene, Stephen Boccuzzi. Coprescription of Triptans With Potentially Interacting Medications: A Cohort Study Involving 240 268 Patients, Headache 2003 43(1):44-48

3. Birmes, P, Coppin, D, Schmitt, L, Lauque, D, Serotonin syndrome:  a brief review, Canadian Medical Association Journal 2003; 168 (11): 1439-1442

4. Dunkley, EJ, Isbister, GK, Sibbritt, D, Dawson, AH, Whyte, IM, The Hunter Serotonin Toxicity Criteria:  simple and accurate diagnostic decision rules for serotonin toxicity, QJM 2003; 96:635-642

By Christina Peterson, MD

Types of headaches described and explained

Different types of headaches

No two people feel or describe pain in exactly the same way.  However, the various types of headaches have symptoms that are fairly consistent.  The descriptions in this category are provided to help you determine what sort of headache you experience.  This is not a substitute for a diagnosis by a doctor, but is meant to provide a general guide.  Read more to see if you have potentially dangerous headaches.

This is also not an exhaustive list of all headache types, but gives an overview of those most commonly encountered.  For those who would like more information about the classification and diagnosis of various headaches, more information can be found in the International Headache Society’s ICDH-3 (International Classification of Headache Disorders, 3rd Edition). 

 

updated Feb 9, 2019

Raynaud’s Disease

Raynaud’s Disease and Migraine

Raynaud’s disease affects 4-15% of the general population.  The female to male predominance is 7:1.  As association has been found between Raynaud’s and migraine.  The symptoms are color changes in the fingers and toes in response to cold exposure.  The digits sometimes turn first white, then blue, and finally red as a reactive phase.  Tingling and numbness can also occur  This happens because of vasospasm, and it is important for your doctor to know about this, because it may affect the choice of medication used to treat your migraines.

Beta-blockers, clonidine, and ergots are contra-indicated as they are vasoconstrictors and can make the condition worse.  Smoking also makes it worse.  However, calcium channel blockers can be used to treat Raynaud’s disease, and this is also a migraine preventive agent.  Biofeedback has also been used for Raynaud’s, and is also useful in migraine.

This is a helpful ink about Raynaud’s